Calliditas Therapeutics

Provider of small molecule based drug for inflammatory kidney disease

placeStockholm, Stockholm County, Sweden calendar_todayFounded 2004 groups40 employees language calliditas.se

Registered entities

Social engagement

Social engagement: 14K social following, 4 posts in the last 12 months — above the industry median.

Investor mix

5 investors on record; lead investors include Investinor.

Investor typeCountShare
Venture capital480%
Private equity120%

Recent activity

12 Nov 2025
Event
High-Impact Clinical Trials session at American Society of Nephrology Kidney Week
12 Nov 2025
Event
High-Impact Clinical Trials session at American Society of Nephrology Kidney Week
4 Nov 2025
Event
ASN Kidney Week
Coming soon